Page 864 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

842 Index

Vemurafenib (Zelboraf), 262 Viral vector (Continued) Whole exome sequencing, 151
Vessel normalization, 263–264 replication-competent, 254 Whole genome sequencing (WGS), 147, 151
Whole tumor cell vaccines, 239
squamous cell carcinoma and, 352–353
Veterinary cancer patients, path to PMED
VetBooks.ir Veterinary contract research organizations, 346 tumor vaccination using, 240 Wide wound margin, 167t
for, 155
Wilms tumor, 10
types of, 252t
Veterinary Cooperative Oncology vaccine, 240 World Health Organization (WHO)
Group-Common Terminology Criteria Virally induced fibrosarcoma, 25 criteria, for nervous system tumors, 657,
for Adverse Events (VCOG-CTCAE), Virus safety, 251–253 658t
341–342 Vitamin, cancer development and, 301–302 lymphoma classification system, 67
Veterinary Medical Database (VMDB), 675 Vitamin A, 309 mast cell tumors staging staging scheme
study Vitamin B, 309 for, 387t
as information source for cancer Vitamin B 12 , 309 oral melanoma staging scheme for,
occurrence, 85 Vitamin D, 301–302 368–369
proportional mortality ratio versus true tumorigenesis and, 309 tumor-node-metastasis, 368f
mortality rate, 83–84, 84f VNP20009, salmonella and, 236 tumor-node-metastasis classification system
Veterinary registration trial, 345 von Hippel-Lindau (VHL) tumor suppressor by, 354
Vimentin, 597 gene, 6 Wound healing
Vinblastine, 195 Vorinostat, 270 chemotherapy and, 170
clinical use of, 195 VPA. see Valproic acid radiation and, 170
grade III/IV neutropenia prevalence with, V-plasty (wedge) or four-sided excision, for Wound margin, classification/resection of,
189f ocular tumors, 677 167t
pharmacology of, 195 aggressiveness of, 168
Vinca alkaloid (vinblastine and vincristine), 195 W malignant cancer control, 167
Vincristine, 195 Warburg, Otto, 8–9, 300 Wright-Giemsa stain, 128–129
clinical use of, 195 Warburg effect, 8–9, 48, 300
pharmacology of, 195 cancer and, 49f X
Vinorelbine, 195 Waste site Xenogenic tyrosinase, for digital malignant
clinical use of, 195 mortality from cancer and, 92 melanoma, 362
pharmacology of, 195 validation studies and, 92
Viral gene delivery, 251, 252f Wasting Y
Viral insertion, 40f, 43 cancer and, 98 90 Yttrium-hydroxide (Y90), 542
Viral long terminal repeat (LTR), 43 cats, 301 Yunnan Baiyao, 334–335
Viral oncogene (v-onc), 41 Weight loss Yunnan Paiyao. see Yunnan Baiyao
cellular oncogenes and, 41 cancer and, 98
Viral papillomatosis, 432 in hospitalized cats, 307–308 Z
Viral plaque, 353 paraneoplastic syndrome and, 98 Zoledronate (ZOL), 548–549
Viral vector Wet smear, 128–129 dose and effects of, 292t
for gene delivery, 251 WGS. see Whole genome sequencing Zollinger-Ellison syndrome, 584
improving specificity of, 253f WHO. see World Health Organization gastrinoma-related, 100